New method revolutionizes DNA-encoded chemical libraries

Nowadays, there’s lots of buzz about spectacular new medical treatments such as personalised cancer therapy with modified immune cells or antibodies.

Zimmer licenses NeuroOne brain ablation system

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Dive Insight: Zimmer acquired exclusive

November 4, 2024

Transformational progress taking shape, profitability impacted by rapid expansion – appointment of Marc Augustin as new CFO – Biotech Investments

PolyPeptide Group / Key word(s): Half Year Results 15-Aug-2023 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer

August 16, 2023

New gene variants linked to early menopause and cancer risk identified

Study reveals nine gene variants linked to ovarian aging and cancer risk, with implications for reproductive longevity and de novo mutation rates.

September 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.